Clinical Outcomes Between Pulsatile and Non-Pulsatile Flow During Cardiopulmonary Bypass

The aim of this prospective, randomized study was to compare clinical outcomes of Pulsatile and non-pulsatile flow during Cardiopulmonary Bypass.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cardiac Surgery Cardiac Surgery Requiring Cardiopulmonary Bypass

Sex eligibility

All sexes

Study type

Observational

Primary location

Tribhuvan University Teaching Hospital, Institute of Medicine (IOM), Kathmandu, Nepal

Kathmandu, 44600, Nepal

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

patients undergoing Atrial Septal Defect closure and Mitral Valve replacement

Exclusion criteria

• Moderate and severe LVEF
• Patient with bleeding dysfunction;AKI ;deranged liver dysfunction\\
• Patient/Surrogate decision maker not giving written informed consent

Treatment and study plan

Bypassing Agents

Procedure

Cardiopulmonary bypass surgery, pulsatile flow

Primary outcomes

ICU Length of Stay

Time frame: 12 months

Measured in days from ICU admission to ICU discharge

Secondary outcomes

Duration of Cardiopulmonary Bypass (CPB)

Time frame: 12 months

Measured in minutes from initiation to termination of bypass

Sponsors and collaborators

Lead sponsor

Tribhuvan University Teaching Hospital, Institute Of Medicine.

Other

Registry information

Important dates

Study start: 2019
Primary completion: 2020
Study completion: 2020
First posted: Jun 8, 2025
Registry last updated: Jun 8, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed